Records containing: Lupus Nephritis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-05-03Precision Medicine in Lups Nephritis: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy
-
CLINICAL_TRIALS study record update · 2022-03-14Unmethylated CpG-rich DNA Fragments in TLR-mediated Renal Fibrogenesis of Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2022-03-09Phenotype of Urinary CD4+ T Cells as Biomarkers for Prediction of Outcome in Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2022-03-09A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
-
CLINICAL_TRIALS study record update · 2022-03-03Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis During the Induction of Remission Period-EUROLUPUS vs. RITUXILUP Regimen: A Randomized Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-01-18A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt
-
CLINICAL_TRIALS study record update · 2021-11-24A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects With Active Proliferative Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2021-11-15Epidemiology of Lupus Nephritis in Nephrology Unit in Assiut University Hospital
-
CLINICAL_TRIALS study record update · 2021-10-20A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis
-
CLINICAL_TRIALS study record update · 2021-10-18The Expression Profile of New Complement Components in Childhood Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2021-10-04Dynamic Imaging of Variation in Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2021-09-23A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis: Pilot Study
-
CLINICAL_TRIALS study record update · 2021-08-19A Phase Ib Study of Milatuzumab Administered Subcutaneously in Patients With Active Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2021-08-03Identification of Biomarkers for Lupus Nephritis Using Urine Exosomes
-
CLINICAL_TRIALS study record update · 2021-07-12A Double-blind, Randomised, Placebo-controlled Trial Evaluating the Effect of BI 655064 Administered as Sub-cutaneous Injections, on Renal Response After One Year of Treatment, in Patients With Active Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2021-06-16A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2021-06-11A Multicentre, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Study to Evaluate the Efficacy and Safety of fSHR-1314 in Adult Patients With Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2021-05-19A Pilot Study of Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2021-05-18A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2021-04-26Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort
-
CLINICAL_TRIALS study record update · 2021-03-19An Exploratory Study Assessing the Short Term Predictors of Remission of Voclosporin 23.7mg Twice Daily (BID) in Combination With Standard of Care in Patients With Active Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2021-02-02A Multicenter, Double-blind, Placebo-controlled, Randomized Trial of Pentoxifylline or Placebo in Addition to Standard of Care for Treatment of Proteinuria in Patients With Lupus Nephritis.
-
CLINICAL_TRIALS study record update · 2021-02-01A Randomized Open-label Study of Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2020-12-22A Randomised, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of Ocrelizumab in Patients With WHO or ISN Class III or IV Nephritis Due to Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2020-10-22High Quality Evidence of Chinese Lupus Nephritis (HELP)